TARO: Taro Pharmaceutical Industries Ltd. - Summary | Jitta

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

Price
$82.36
Loss Chance
43.1%
5.15JITTA SCORE
6.20%Above Jitta Line
Jitta Ranking
84 / 837
1,336 / 4,780
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (15)
Recent Business Performance (20)
Financial Strength (100)
Return to Shareholders (68)
Competitive Advantage (74)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
CapExVery Low
Revenue and EarningRevenue decline from 2016-2019
Key Stats
Jitta Score
Jitta Line
5.15
6.20%
2.19
0.60%
Pharmaceuticals
2.30
100.00%
1.65
14.81%
3.90
115.67%
COMPANY DESCRIPTION
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. It also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. The company offers its products primarily in the areas of topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, anti-inflammatory, and other therapeutic categories. The company distributes and sells its products directly to wholesalers, retail drug store chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.